drugset / Trial / NCT06007547

Prophylactic Minimally Invasive Surfactant Evaluation

NCT06007547

Phase 4 Recruiting 200 enrolled Endeavor Health Chiesi USA, Inc. · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to explore the question: Does prophylactic administration of exogenous surfactant in the delivery room, using a minimally-invasive technique, improve outcome in preterm infants 22-29 weeks' gestation compared to rescue treatment using the same technique?

Timeline

Start
2024-01-01
Primary completion
2025-12-31
Completion
2027-07-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Poractant alfa Other / unclassified 200 mg/kg Other